About Technology Why It Matters Features Vision Team Contact
Now Seeking Investors & Clinical Partners

AI-Powered Early
Leukemia Detection

Transforming healthcare through artificial intelligence, blood diagnostics, and future medical innovation. Built for doctors. Designed to save lives.

0% Detection Accuracy
0x Faster Diagnosis
0+ Cases/Year Globally
0 Founded
Scroll
About UMIT AI

Revolutionizing
Disease Detection

Our mission is to revolutionize early disease detection using AI and medical innovation. We build intelligent clinical systems that empower doctors to make faster, more accurate decisions โ€” ultimately saving more lives.

๐Ÿฉธ
Early Leukemia Detection
AI-driven blood analysis identifying cancer markers with 95%+ accuracy
๐Ÿค–
AI Clinical Assistant
Intelligent medical chatbot supporting doctors at every step
๐Ÿ“Š
Smart Diagnostics
Real-time patient dashboards with trend monitoring & risk scores
๐Ÿ”ฌ
Future Expansion
Genomic engineering, artificial organs & smart therapeutics
"Our mission is to use AI to detect disease before symptoms appear โ€” giving patients more time, and doctors more power."
0
New leukemia cases per year worldwide
0
Survival rate with early detection
0
Better outcomes with AI-assisted care
Core Technology

Powered by AI & Innovation

Our proprietary technology stack combines state-of-the-art machine learning with clinical-grade blood analysis to deliver breakthrough diagnostics.

๐Ÿง 
Machine Learning
Deep neural networks trained on thousands of annotated blood sample datasets to recognize leukemia markers with precision.
๐Ÿฉธ
Blood Data Analysis
Advanced CBC (Complete Blood Count) interpretation engine that identifies abnormal patterns invisible to the naked eye.
๐Ÿ“ˆ
Risk Score Prediction
Real-time risk stratification algorithms that calculate individual patient risk indexes and flag high-priority cases.
๐Ÿฅ
Clinical Decision Support
Evidence-based recommendations integrated into physician workflows to enhance clinical decision-making confidence.
๐Ÿ’ฌ
AI Medical Chat Assistant
LLM-powered clinical assistant that explains diagnoses, suggests next steps, and answers complex medical queries in real-time.
๐Ÿ”
Secure Infrastructure
End-to-end encrypted, HIPAA-compliant cloud infrastructure ensuring maximum patient data protection and regulatory compliance.
Why It Matters

A Global Health Crisis We Can Solve

0
New Leukemia Cases
diagnosed worldwide every year
0
Survival Rate
when detected in early stages
0
Late Detection Rate
current global average โ€” too late
0
Market Opportunity
in AI-powered diagnostics by 2030

Early Detection Changes Everything

When leukemia is caught early, treatment success rates skyrocket. UMIT AI makes that possible at scale.

โค๏ธ
Life-Saving Early Diagnosis
AI detects leukemia signals up to 18 months before traditional methods, dramatically improving treatment outcomes.
โšก
3x Faster Clinical Workflow
Automated analysis reduces doctor workload, allowing more patients to be screened per day without sacrificing accuracy.
๐ŸŒ
Global Reach & Accessibility
Cloud-based platform enables world-class leukemia screening in resource-limited settings across developing nations.
๐Ÿ’ฐ
Massive Cost Reduction
Early detection reduces treatment costs by up to 60%, saving healthcare systems billions in advanced-stage care.
Platform Features

Built for Medical Professionals

A secure, doctor-only platform engineered for clinical precision, speed, and trust.

01
๐Ÿ”’
Doctor-Only Secure Platform
Role-based authentication system with medical license verification. No unauthorized access. Full audit trails for every action.
02
๐Ÿ“Š
Patient Blood Analysis Dashboard
Interactive visualization of blood test results with AI-highlighted anomalies, historical trends, and comparative analysis.
03
๐Ÿง 
AI Explanation Engine
Transparent AI โ€” every prediction comes with a detailed explanation of which blood markers drove the diagnosis and why.
04
๐Ÿ“‰
Trend Monitoring
Long-term patient health tracking across multiple visits. Automatically flags worsening trends before they become critical.
05
๐ŸŒ
Multi-Language Support
Available in English, Spanish, Russian, Kazakh, and 10+ languages โ€” enabling global adoption across diverse medical communities.
06
๐Ÿ”‘
Enterprise Authentication
SSO integration, 2FA, hospital network support, and full HIPAA/GDPR compliance. Enterprise-ready from day one.
Future Vision

The Road to Tomorrow's Medicine

UMIT AI is not just a diagnostic tool. It is the foundation of a new era of intelligent medicine.

Phase 1 โ€” Current
2026
๐Ÿฉธ Leukemia Detection Platform
Launch of the core AI blood analysis engine. Partnering with leading clinics. Achieving 95%+ detection accuracy in clinical trials.
Phase 2
2027
๐Ÿ”ฌ Multi-Cancer Expansion
Extending AI capabilities to detect lymphoma, myeloma, and other blood-related cancers. Global clinical partnerships and regulatory approvals.
Phase 3
2028
๐Ÿงฌ Genomic Intelligence
Integration of genomic engineering data for personalized medicine. Predicting genetic predispositions and tailoring treatment protocols to individual DNA profiles.
Phase 4
2029+
๐Ÿค– Smart Therapeutics & AI Organs
Development of AI-guided therapeutic systems and research into artificial organ technology. Positioning UMIT AI at the frontier of post-human medicine.
Opportunities

Partner with UMIT AI

Join us in building the future of medical AI. We welcome strategic investors, clinical partners, and global media.

๐Ÿ“ˆ
Investor Relations
We are raising our Seed round to scale clinical trials and expand globally. Join us in solving one of medicine's greatest challenges.
Invest in UMIT AI
๐Ÿฅ
Clinical Partnerships
We are seeking hospitals, oncology centers, and diagnostic labs to run pilot programs and validate our AI at scale.
Partner With Us
๐Ÿ“ฐ
Media Contact
Covering MedTech, AI, or healthcare innovation? We welcome press inquiries, interviews, and feature stories about UMIT AI.
Press Inquiry

Ready to Save Lives
with Artificial Intelligence?

Book a demo. Join as a partner. Help us transform early cancer detection for the world.

Leadership

Meet the Team

The minds building tomorrow's medical AI โ€” driven by science, purpose, and innovation.

๐Ÿ‘จโ€โš•๏ธ
Founder & Chief Executive Officer

Yermukhan Talapov

Visionary entrepreneur and AI innovator dedicated to transforming global healthcare. Founded UMIT AI with a bold mission: detect leukemia earlier and save more lives through the power of machine learning and biomedical engineering.

๐Ÿค– AI Engineer ๐Ÿงฌ BioMedTech Founder ๐ŸŒ Visionary Leader
๐Ÿ‘จโ€๐Ÿ’ป
Co-Founder & Chief Technology Officer

Bizhan Alizhan

Expert AI & ML engineer architecting the core intelligence behind UMIT AI. Bizhan leads the design and development of deep learning models for blood data analysis, driving the technical excellence that makes our 95%+ detection accuracy possible.

๐Ÿง  ML Engineer โš™๏ธ AI Architect ๐Ÿ“Š Deep Learning
Get In Touch

Let's Build Together

Whether you're an investor, clinic director, or journalist โ€” we'd love to hear from you.

๐Ÿ“ž
Phone
+7 708 368 1281
โœ‰๏ธ
Email
etalapov0@gmail.com
๐Ÿ“ธ
Instagram
@talapovee_
Why work with us?
โœ“ World-class AI research team
โœ“ Clinically validated technology
โœ“ HIPAA & GDPR compliant platform
โœ“ Global expansion roadmap ready
โœ“ Seed round โ€” strong ROI potential